VENTAS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.48 EUR | +2.46% |
|
+1.63% | +3.98% |
| 06-21 | Raymond James Adjusts Price Target on Ventas to $55 From $50.26 | MT |
| 06-20 | BNP Paribas Exane Adjusts Price Target on Ventas to $59 From $54 | MT |
| Sales 2024 * | 4.84B 4.52B 6.63B | Sales 2025 * | 5.12B 4.79B 7.02B | Capitalization | 20.53B 19.19B 28.13B |
|---|---|---|---|---|---|
| Net income 2024 * | 12M 11.22M 16.44M | Net income 2025 * | 133M 124M 182M | EV / Sales 2024 * | 6.91 x |
| Net Debt 2024 * | 12.89B 12.05B 17.65B | Net Debt 2025 * | 12.86B 12.03B 17.62B | EV / Sales 2025 * | 6.52 x |
| P/E ratio 2024 * |
587
x | P/E ratio 2025 * |
160
x | Employees | 486 |
| Yield 2024 * |
3.58% | Yield 2025 * |
3.75% | Free-Float | 99.39% |
More Fundamentals
* Assessed data
More news
Latest transcript on Ventas, Inc.
More recommendations
More news
| 1 day | +2.35% | ||
| 1 week | +1.63% | ||
| Current month | +4.88% | ||
| 1 month | +8.62% | ||
| 3 months | +19.11% | ||
| 6 months | +3.98% | ||
| Current year | +3.98% |
1 week
46.34
47.25
1 month
43.1147.25
Current year
38.9347.25
1 year
37.1747.25
3 years
37.0157.04
5 years
15.2268.19
10 years
15.2271.56
| Managers | Title | Age | Since |
|---|---|---|---|
Debra Cafaro
CEO | Chief Executive Officer | 66 | 98-12-31 |
Bob Probst
DFI | Director of Finance/CFO | 56 | 14-10-26 |
| Chief Tech/Sci/R&D Officer | - | 19-01-24 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michael Embler
BRD | Director/Board Member | 60 | 22-03-06 |
Matthew Lustig
BRD | Director/Board Member | 63 | 11-05-11 |
Marguerite Nader
BRD | Director/Board Member | 55 | 20-07-05 |
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 47.25 | +1.96% |
| 24-06-27 | 46.34 | -0.11% |
| 24-06-26 | 46.39 | -1.34% |
| 24-06-25 | 47.02 | +0.32% |
| 24-06-24 | 46.87 | +0.82% |
Delayed Quote Deutsche Boerse AG, June 28, 2024 at 02:03 am
More quotes
Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities.
At the end of 2022, the group's portfolio included 1,237 assets consisting primarily of senior housing (802), medical office buildings (313), rehabilitation and long-term acute care facilities (36), laboratories and research facilities (32), skilled nursing facilities (16), medical and surgical facilities (13).
Net sales are distributed geographically as follows: the United States (88.5%), Canada (10.9%) and the United Kingdom (0.6%).
Sector
Specialized REITs
Calendar
2024-06-30
- Détachement de
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
50.81
USD
Average target price
54.56
USD
Spread / Average Target
+7.37%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +15.17% | 61.79B | |
| +10.89% | 8.33B | |
| -4.76% | 6.3B | |
| +11.08% | 3.6B | |
| +6.83% | 3.5B | |
| +20.04% | 2.93B | |
| -10.84% | 2.89B | |
| -6.82% | 2.8B | |
| +9.22% | 2.53B |
- Stock Market
- Equities
- VTR Stock
- VEN Stock
